Clinical trial
S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC
NCT03457337
Study timeline
Study start (actual)2018-03-28Date precision: day
Registry last updated2020-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced NSCLC With EGFR Mutationunresolved
Interventions
GefitinibDRUG · verified · RxNorm: gefitinib
Sponsors & collaborators
Henan Cancer Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03457337 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.